Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labor induction after premature rupture of membranes with unfavorable cervix: oxytocin versus misoprostol
RBR-39rmvbPhase 4Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxytocin, misoprostol in Rupture of amniotic membranes (PROM), sponsored by Hospital de Clínicas de Porto Alegre. Started Mar 2020; status: recruiting.
02
Drugs
oxytocinmisoprostol
03
Conditions
Rupture of amniotic membranes (PROM)
Beyond the preview
Go deeper on RBR-39rmvb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-39rmvb.